Locations:
Search IconSearch
April 17, 2026/Neurosciences/Podcast

Updated Brain-Death Guidelines Add Specificity (Podcast)

Newer protocols address testing, language and communication

As one of medicine’s most definitive diagnoses, brain death can also be one of its most difficult for physicians and families. Clinical exposure to brain death has becomes less common while the expectation of precision continues to rise.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Brain death is the death of [both] a brain and brainstem as a whole function, which can be difficult for many people to understand,” says Cleveland Clinic neurointensivist Dhimant Dani, MD. “They see that a brain is not working, but then they also see that the heart is beating.”

In the latest episode of the Neuro Pathways podcast, Dr. Dani joins Glen Stevens, DO, PhD, to discuss updated guidelines for determining brain death. In 2023, the American Academy of Neurology released new consensus guidelines, which included updating terminology from simply “brain death” to “brain death/death by neurologic criteria” (BD/DNC).

Other key changes included recommendations for both pediatric and adult patients in a single document; requirements for brain-death determination; criteria for examinations and examiners; apnea testing; ancillary testing; and communicating about brain death and declaring brain death to families.

“When we think of a brain-death exam, it starts with the prerequisite. Is the patient meeting that prerequisite?” says Dr. Dani. “The very important thing is that the injury to the brain has to be permanent. There should not be any form of reversibility.

Once that is determined, major confounders must be ruled out. That includes anything that can cause symptoms that mimic death, such as hypothermia, shock, metabolic derangements, certain medication and certain trauma injuries. Then, says Dr. Dani, a brain imaging CAT scan must support the diagnosis of irreversible brain injury.”

Advertisement

The podcast conversation also touches on:

  • How brain death differs from coma and the vegetative state
  • Why a neuroimaging is necessary
  • How brainstem reflexes and apnea testing are assessed
  • When ancillary testing is appropriate
  • Why EEG is now considered obsolete in this setting
  • The challenge of limited provider exposure and training

Click the podcast player above to listen to the 29-minute episode now, or read on for a short, edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™ and ANCC contact hours. After listening to the podcast, you can claim your credit here.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD:

The new guidelines, do they add specificity? Are they more objective? I assume that answer would be yes to that, but any specific examples?

Dhimant Dani, MD: There is more specificity, as well as there is more objectiveness to the new guidelines, which really helps a physician. A lot of nuances, like “normalization of metabolic derangement,” or a broader term, like “fixing metabolic issues” or “no major metabolic derangement” have been taken off.

Giving you an example, a specific temperature goal, which is … 36 degrees centigrade and above, in the past was not that as specific as what it is in 2023 guideline. Same thing with hemodynamic parameters, like a systolic blood pressure, but also adding a mean arterial pressure together. That has also added further guidance and stricter guidance for physicians to apply when they are performing a brain death (exam).

Advertisement

And, there is a new support and guideline for when to perform ancillary testing. Ancillary testing does not replace the brain death examination, but it supports the brain death examination. As you know, that ancillary testing does not focus on brain function, but on blood flow. When we think brain is dead, we think that that means that there should not be any blood flow to the brain. The ancillary test supports the diagnosis of lack of blood flow to the brain, which is something that is important. There has been more guidance on what level of metabolic derangement can cause changes in mental status and so forth. It has been described in a better way in the new guideline, and that is a very helpful and more accurate.

Advertisement

Related Articles

portrait of Dr. Robert Bermel against a decorative backdrop with podcast icon overlay
July 2, 2026/Neurosciences/Podcast

Inside Our New Neurological Assessment Center (Podcast)

Reimagining the outpatient neurological visit with routine capture of neuroperformance data

woman in white medical coat typing on a laptop in lab setting
June 30, 2026/Neurosciences/Epilepsy

Online Tool Makes It Easier to Share and Analyze Data on Epilepsy-Related Cognitive Disorders

Free portal helps researchers classify and share data using the IC-CoDE framework

woman in wheelchair being wheeled into or out of an elevator

Key Rural-Urban Differences Revealed in U.S. Post-Acute Stroke Care

Large study shows rural patients are less apt to be discharged to inpatient rehab, hampering outcomes

portrait of Dr. Jeffrey Cohen against decorative background with podcast icon overlay
June 16, 2026/Neurosciences/Podcast

The Potential of CAR T-Cell Therapy in Multiple Sclerosis (Podcast)

Updates on this fast-evolving therapeutic landscape from a leading trialist

rendering of a two-tower medical building

New Building to Showcase the Potential of a Hybrid OR in Neurosurgery Care

Advanced surgical suite in our soon-to-open facility promises to redefine care standards

middle-aged woman looking down sadly while sitting on a bed

Multiple Sclerosis Progression in Midlife Women: Disentangling Reproductive and Somatic Aging

Two research projects aim to enable more personalized MS care in this population

medical team rushing patient on gurney through hospital hallway

Even With Gains in Quality Metrics, Inpatient Stroke Care Lags Community Stroke Care

Inferior clinical outcomes continue into mechanical thrombectomy era, large analysis finds

neuron-affected-by-neuromyelitis-optica

NMOSD: Multiple Monoclonal Antibodies Have Expanded Treatment Options

How to use? Consider starting during the acute attack and seek patient preferences for chronic use

Ad